TrialThe oncologist2021

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703).

Yihebali Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.